Risk factors

Dr Darren McGuire on why cardiologists should consider specific antihyperglycaemic agents for CV risk mitigation

Sponsored by Boehringer Ingelheim Pty Ltd

Dr Darren McGuire from UT Southwestern Medical Center in Dallas, Texas, has expertise in clinical trial design and execution of large-scale cardiovascular outcomes studies, with a focus in the area of diabetes and cardiovascular disease. This places him at the forefront of an emerging treatment paradigm in cardiology where specific antihyperglycaemic agents are used for ...

Already a member?

Login to keep reading.

© 2021 the limbic